TITLE

Hemodynamic Assessment of Pharmacological Response in the Treatment of Portal Hypertension: A Need to Know

AUTHOR(S)
Grace, Norman D.
PUB. DATE
August 2000
SOURCE
American Journal of Gastroenterology;Aug2000, Vol. 95 Issue 8, p1862
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Offers observation on a meta-analysis of seven published randomized controlled trials comparing a nonselective β-adrenergic blocker to a placebo or no treatment for the prevention of initial variceal hemorrhage. Risk of hemorrhage from varices in patients with cirrhosis and large esophageal varices; Incidence of bleeding in the β-blocker-treated patients; Basis of the data to support the value of repeat hepatic venous pressure gradient measurement in assessing the efficacy of pharmacological therapy for portal hypertension.
ACCESSION #
17651267

 

Related Articles

  • Propranolol in Primary and Secondary Prophylaxis of Variceal Bleeding Among Cirrhotics in India: A Hemodynamic Evaluation. De, Binay K.; Sen, Sambit; Biswas, Pranab K.; Sengupta, Debapriya; Biswas, Jayanta; Santra, Amal; Hazra, Baburam; Maity, Ajit K. // American Journal of Gastroenterology;Aug2000, Vol. 95 Issue 8, p2023 

    OBJECTIVE: In the present study, we attempted to complete the hemodynamic assessment of propranolol response in cirrhotics with esophageal varices at high risk of bleeding, in one sitting, so as to identify nonresponders at the earliest. Some noninvasive indicators of this response were also...

  • Benefit of combination β-blocker and endoscopic treatment to prevent variceal rebleeding: A meta-analysis. Funakoshi, Natalie; Ségalas-Largey, Frédérique; Duny, Yohan; Oberti, Frédéric; Valats, Jean-Christophe; Bismuth, Michael; Daurès, Jean-Pierre; Blanc, Pierre // Annals of Gastroenterology & Hepatology;2011, Vol. 9 Issue 96, p5982 

    AIM: To determine whether the association of β-blockers with endoscopic treatment is superior to endoscopic treatment alone for the secondary prophylaxis of oesophageal variceal bleeding. METHODS: Randomised controlled trials comparing sclerotherapy (SCL) with SCL plus β-blockers (BB) or...

  • Factors Predicting the Presence of Esophageal or Gastric Varices in Patients With Advanced Liver Disease. Zaman, Atif; Hapke, Ronald; Flora, Kenneth; Rosen, Hugo R.; Benner, Kent // American Journal of Gastroenterology;Nov1999, Vol. 94 Issue 11, p3292 

    OBJECTIVE: Recently it has been recommended that all cirrhotic patients without previous variceal hemorrhage undergo endoscopic screening to detect varices and that those with large varices should be treated with β-blockers (American College of Gastroenterology guidelines). However,...

  • Massive Variceal Bleeding Caused by Scuba Diving. Nguyen, Michelle H.; Ernsting, Kevin S.; Proctor, Deborah D. // American Journal of Gastroenterology;Dec2000, Vol. 95 Issue 12, p3677 

    Describes a case of massive variceal bleeding caused by scuba diving. Information on variceal bleeding; Impact of portal pressure in the occurrence of variceal bleeding; Information on the physiological response of patients with chronic portal hypertension to central venous pressure.

  • Carvedilol in the Treatment of Portal Hypertension. Al-Ghamdi, Hamdan // Saudi Journal of Gastroenterology;Mar2011, Vol. 17 Issue 2, p155 

    Variceal bleeding is a major event in the natural history of end-stage liver disease with a subsequent high mortality rate. Non-selective β-blockers are currently the drugs of choice for preventing first variceal bleeding. Endoscopic rubber band ligation of high risk varices features as a...

  • A nonselective β-blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension.  // ACP Journal Club;May/Jun2006, Vol. 144 Issue 3, p68 

    The article discusses a study which determines whether a nonselective β-adrenergic blocker prevents gastroesophageal varices. 213 patients with cirrhosis and portal hypertension and without gastroesophageal varices were included in the study. The study drug was discontinued in 23% of patients...

  • Adherence and Adequacy of Therapy for Esophageal Varices Prophylaxis. Maddur, Haripriya; Naik, Suraj; Siddiqui, Ali; Rockey, Don // Digestive Diseases & Sciences;Nov2011, Vol. 56 Issue 11, p3129 

    Aims: Esophageal varices (EVs) are prevalent among cirrhotics and their bleeding leads to substantial morbidity and mortality. Management guidelines available during this study recommended beta-blocker therapy for primary prophylaxis and beta-blocker or band ligation (EVL) for secondary...

  • Pro: Cirrhotic Patients With Small Esophageal Varices Should Undergo Primary Prophylaxis. Giannini, Edoardo G. // American Journal of Gastroenterology;Sep2009, Vol. 104 Issue 9, p2132 

    The article focuses on the issue concerning the risk of prophylactic intervention to patients suffering from liver cirrhosis with small esophageal varices. It cites that primary prophylaxis with beta-blockers is ideal in preventing high risk of bleeding in patients with small varices. It also...

  • PREVENTION OF RECURRENT VARICEAL HEMORRHAGE: TO BLOCK OR NOT TO BLOCK? Avezzano, Eric S.; Seefe, Leonard B.; Johnson, David A.; Cattau, Edward // American Journal of Gastroenterology;May1990, Vol. 85 Issue 5, p614 

    Comments on a study about the effect of β-blockade on recurrent gastrointestinal bleeding in patients with alcoholic cirrhosis. Three forms of management of esophageal varices; Effectiveness of propanolol compared to atenol in preventing rebleeding; Failure to demonstrate a significant...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics